176 related articles for article (PubMed ID: 26275218)
21. Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.
Chen G; Cheng Y; Tang Y; Martinka M; Li G
J Invest Dermatol; 2012 Nov; 132(11):2632-41. PubMed ID: 22673729
[TBL] [Abstract][Full Text] [Related]
22. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
[TBL] [Abstract][Full Text] [Related]
23. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
24. Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
Murtas D; Piras F; Minerba L; Ugalde J; Floris C; Maxia C; Demurtas P; Perra MT; Sirigu P
Oncol Rep; 2010 Feb; 23(2):329-35. PubMed ID: 20043092
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
Wang Y; Dai DL; Martinka M; Li G
Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
[TBL] [Abstract][Full Text] [Related]
27. Nuclear ING2 expression is reduced in human cutaneous melanomas.
Lu F; Dai DL; Martinka M; Ho V; Li G
Br J Cancer; 2006 Jul; 95(1):80-6. PubMed ID: 16755297
[TBL] [Abstract][Full Text] [Related]
28. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
29. Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.
Nikolaishvilli-Feinberg N; Cohen SM; Midkiff B; Zhou Y; Olorvida M; Ibrahim JG; Omolo B; Shields JM; Thomas NE; Groben PA; Kaufmann WK; Miller CR
J Histochem Cytochem; 2014 Mar; 62(3):185-96. PubMed ID: 24309508
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients.
Rotte A; Bhandaru M; Cheng Y; Sjoestroem C; Martinka M; Li G
PLoS One; 2013; 8(9):e75405. PubMed ID: 24098694
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
Rangel J; Torabian S; Shaikh L; Nosrati M; Baehner FL; Haqq C; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
J Clin Oncol; 2006 Oct; 24(28):4565-9. PubMed ID: 17008696
[TBL] [Abstract][Full Text] [Related]
33. Loss of SNF5 expression correlates with poor patient survival in melanoma.
Lin H; Wong RP; Martinka M; Li G
Clin Cancer Res; 2009 Oct; 15(20):6404-11. PubMed ID: 19808872
[TBL] [Abstract][Full Text] [Related]
34. Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.
Kielhorn E; Provost E; Olsen D; D'Aquila TG; Smith BL; Camp RL; Rimm DL
Int J Cancer; 2003 Feb; 103(5):652-6. PubMed ID: 12494474
[TBL] [Abstract][Full Text] [Related]
35. CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: assessment by the use of tissue microarray.
Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
Int J Cancer; 2006 Mar; 118(6):1460-4. PubMed ID: 16187282
[TBL] [Abstract][Full Text] [Related]
36. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
Meyer S; Wild PJ; Vogt T; Bataille F; Ehret C; Gantner S; Landthaler M; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
Exp Dermatol; 2010 Aug; 19(8):e251-7. PubMed ID: 20500769
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.
Pieniazek M; Donizy P; Halon A; Leskiewicz M; Matkowski R
Biomark Med; 2016 Sep; 10(9):975-85. PubMed ID: 27586584
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis.
Chen X; Liu X; Deng B; Martinka M; Zhou Y; Lan X; Cheng Y
Sci Rep; 2018 Nov; 8(1):16867. PubMed ID: 30442923
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
40. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R
Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
